Breast cancer is the most common type of cancer among Thai women and women around the world. Today, the number of people with this disease increases every year. The early stages of breast cancer often do not show signs or symptoms. The patient is aware that the cancer has spread to the third to fourth. Breast cancer treatment in the past surgery, chemotherapy, anti-hormonal treatment, but in the past year there is another alternative treatment. After the United States Pfizer. The innovative drug for breast cancer in spreading and spreading. In Thailand, this drug has been approved by the drug. Last year, Pfizer donated drugs to the Thai Oncology Society last year. For treatment of 50 patients with metastatic breast cancer, Professor Sirionfong Wirog, Head of the Center for Medical Excellence Cancer Complete King Chulalongkorn Memorial Hospital President of the Oncology Association of Thailand said that the drug is an anti-cancer drug that inhibits the action of CDK 4/6, which Was approved by the Food and Drug Administration as the first drug. The first line in patients with advanced breast cancer or metastatic ER + / HER 2-menopause. Dr. Wierog said that the drug has two formulas that will be used differently.The first formulation is used by patients who have never received hormone therapy. […]
Post Breast Cancer Drug. Increasing survival rate 2 times first appeared on states.